IS8477A - Beta-laktöm til að meðhöndla MTK sjúkdóma - Google Patents

Beta-laktöm til að meðhöndla MTK sjúkdóma

Info

Publication number: IS8477A
Authority: IS; Iceland
Prior art keywords: mtk; lactam; beta; disease; treatment
Prior art date: 2003-11-12

Application number

IS8477A

Other languages

English (en)

Inventor

Alvaro Giuseppe

Di Fabio Romano

Giovannini Riccardo

Mattioli Lucia

Paio Alfredo

Elvira Tranquillini Maria

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-12

Filing date

2006-05-22

Publication date

2006-05-22

2006-05-22 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2006-05-22 Publication of IS8477A publication Critical patent/IS8477A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS8477A 2003-11-12 2006-05-22 Beta-laktöm til að meðhöndla MTK sjúkdóma IS8477A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0326407.4A GB0326407D0 (en)	2003-11-12	2003-11-12	Chemical compounds
PCT/EP2004/012772 WO2005049600A1 (en)	2003-11-12	2004-11-10	Beta-lactams for treatment of cns disorders

Publications (1)

Publication Number	Publication Date
IS8477A true IS8477A (is)	2006-05-22

Family

ID=29726427

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8477A IS8477A (is)	2003-11-12	2006-05-22	Beta-laktöm til að meðhöndla MTK sjúkdóma

Country Status (27)

Country	Link
US (1)	US20080262041A1 (is)
EP (1)	EP1689737B1 (is)
JP (1)	JP2007510692A (is)
KR (1)	KR20060118477A (is)
CN (1)	CN1878764A (is)
AR (1)	AR046233A1 (is)
AT (1)	ATE401321T1 (is)
AU (1)	AU2004291296B2 (is)
BR (1)	BRPI0416285A (is)
CA (1)	CA2546007A1 (is)
CY (1)	CY1108404T1 (is)
DE (1)	DE602004015144D1 (is)
DK (1)	DK1689737T3 (is)
ES (1)	ES2310295T3 (is)
GB (1)	GB0326407D0 (is)
HR (1)	HRP20080501T3 (is)
IL (1)	IL175279A0 (is)
IS (1)	IS8477A (is)
MA (1)	MA28156A1 (is)
MY (1)	MY138378A (is)
NO (1)	NO20062661L (is)
PL (1)	PL1689737T3 (is)
PT (1)	PT1689737E (is)
RU (1)	RU2006120417A (is)
SI (1)	SI1689737T1 (is)
TW (1)	TW200528439A (is)
WO (1)	WO2005049600A1 (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1981844A1 (en) *	2006-01-24	2008-10-22	Biosignal Limited	Novel lactams
AU2015200142B2 (en) *	2006-01-24	2016-07-07	Unilever Plc	Novel lactams

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL130088C (is) *	1960-03-14
FR2676055B1 (fr) *	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0545478A1 (en) *	1991-12-03	1993-06-09	MERCK SHARP & DOHME LTD.	Heterocyclic compounds as tachykinin antagonists
GB9200535D0 (en) *	1992-01-10	1992-02-26	Fujisawa Pharmaceutical Co	New compound
US5824690A (en) *	1993-05-06	1998-10-20	Hoechst Marion Roussel Inc.	Substituted pyrrolidin-3-yl-alkyl-piperidines
GB9317104D0 (en) *	1993-08-17	1993-09-29	Zeneca Ltd	Therapeutic heterocycles
GB9322643D0 (en) *	1993-11-03	1993-12-22	Zeneca Ltd	Lactam derivatives
NZ292683A (en) *	1994-08-25	1998-07-28	Merrell Pharma Inc	Piperidine derivatives
US5780466A (en) *	1995-01-30	1998-07-14	Sanofi	Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
TW332201B (en) *	1995-04-06	1998-05-21	Janssen Pharmaceutica Nv	1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
US6211199B1 (en) *	1995-11-17	2001-04-03	Aventis Pharmaceuticals Inc.	Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
FR2779429B1 (fr) *	1998-06-03	2000-07-13	Synthelabo	Derives d'oxindole, leurs preparations et leurs applications en therapeutique
US6204265B1 (en) *	1998-12-23	2001-03-20	Schering Corporation	Substituted oximes and hydrazones as neurokinin antagonists
GB0114867D0 (en) *	2001-06-18	2001-08-08	Merck Sharp & Dohme	Therapeutic agents
GB0412865D0 (en) *	2004-06-09	2004-07-14	Glaxo Group Ltd	Chemical compounds

2003
- 2003-11-12 GB GBGB0326407.4A patent/GB0326407D0/en not_active Ceased
2004
- 2004-11-10 MY MYPI20044708A patent/MY138378A/en unknown
- 2004-11-10 JP JP2006538791A patent/JP2007510692A/ja active Pending
- 2004-11-10 CA CA002546007A patent/CA2546007A1/en not_active Abandoned
- 2004-11-10 PL PL04797809T patent/PL1689737T3/pl unknown
- 2004-11-10 WO PCT/EP2004/012772 patent/WO2005049600A1/en not_active Ceased
- 2004-11-10 AT AT04797809T patent/ATE401321T1/de active
- 2004-11-10 DK DK04797809T patent/DK1689737T3/da active
- 2004-11-10 ES ES04797809T patent/ES2310295T3/es not_active Expired - Lifetime
- 2004-11-10 SI SI200430872T patent/SI1689737T1/sl unknown
- 2004-11-10 EP EP04797809A patent/EP1689737B1/en not_active Expired - Lifetime
- 2004-11-10 CN CNA2004800333979A patent/CN1878764A/zh active Pending
- 2004-11-10 BR BRPI0416285-4A patent/BRPI0416285A/pt not_active IP Right Cessation
- 2004-11-10 AU AU2004291296A patent/AU2004291296B2/en not_active Ceased
- 2004-11-10 PT PT04797809T patent/PT1689737E/pt unknown
- 2004-11-10 KR KR1020067009274A patent/KR20060118477A/ko not_active Abandoned
- 2004-11-10 RU RU2006120417/04A patent/RU2006120417A/ru not_active Application Discontinuation
- 2004-11-10 US US10/595,662 patent/US20080262041A1/en not_active Abandoned
- 2004-11-10 HR HR20080501T patent/HRP20080501T3/xx unknown
- 2004-11-10 TW TW093134192A patent/TW200528439A/zh unknown
- 2004-11-10 DE DE602004015144T patent/DE602004015144D1/de not_active Expired - Lifetime
- 2004-11-10 AR ARP040104145A patent/AR046233A1/es not_active Application Discontinuation
2006
- 2006-04-27 IL IL175279A patent/IL175279A0/en unknown
- 2006-05-11 MA MA29020A patent/MA28156A1/fr unknown
- 2006-05-22 IS IS8477A patent/IS8477A/is unknown
- 2006-06-09 NO NO20062661A patent/NO20062661L/no not_active Application Discontinuation
2008
- 2008-10-08 CY CY20081101120T patent/CY1108404T1/el unknown

Also Published As

Publication number	Publication date
MA28156A1 (fr)	2006-09-01
PL1689737T3 (pl)	2008-12-31
CA2546007A1 (en)	2005-06-02
TW200528439A (en)	2005-09-01
ATE401321T1 (de)	2008-08-15
KR20060118477A (ko)	2006-11-23
EP1689737B1 (en)	2008-07-16
ES2310295T3 (es)	2009-01-01
AU2004291296B2 (en)	2011-04-07
NO20062661L (no)	2006-06-09
EP1689737A1 (en)	2006-08-16
MY138378A (en)	2009-05-29
CN1878764A (zh)	2006-12-13
PT1689737E (pt)	2008-10-24
DE602004015144D1 (de)	2008-08-28
AR046233A1 (es)	2005-11-30
HK1094698A1 (en)	2007-04-04
DK1689737T3 (da)	2008-10-27
AU2004291296A1 (en)	2005-06-02
US20080262041A1 (en)	2008-10-23
CY1108404T1 (el)	2014-02-12
WO2005049600A1 (en)	2005-06-02
IL175279A0 (en)	2006-09-05
JP2007510692A (ja)	2007-04-26
BRPI0416285A (pt)	2007-01-23
SI1689737T1 (sl)	2008-12-31
HRP20080501T3 (en)	2008-11-30
RU2006120417A (ru)	2007-12-27
GB0326407D0 (en)	2003-12-17

Publication	Publication Date	Title
CY2013022I1 (el)	2020-05-29	Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
HUS1500034I1 (hu)	2017-12-31	Indolidon-származékok fibrózisos betegségek kezelésére vagy megelõzésére
IS8142A (is)	2005-11-23	Læknislyf gagnleg til meðferðar á verkjum
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20053211D0 (no)	2005-06-30	Forbindelser for behandling av metabolske forstyrrelser.
NO20053041D0 (no)	2005-06-21	Behandling av diabetes.
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
CY2015025I2 (el)	2016-04-13	Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
NO20052914D0 (no)	2005-06-15	Terapeutiske forbindelser
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
NO20052058D0 (no)	2005-04-27	Behandling av influensa.
ATE410430T1 (de)	2008-10-15	2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE602005026984D1 (de)	2011-04-28	Chinolin-derivate zur behandlung von latenter tuberkulose
PL1708991T3 (pl)	2008-02-29	Pochodne sulfonoamidu do leczenia chorób
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
NL1026203A1 (nl)	2004-11-16	Verbindingen toepasbaar voor de behandeling van ziekten.
EP1556085A4 (en)	2012-08-22	COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
NO20033804D0 (no)	2003-08-26	Karbamatforbindelser for behandling av smerte
DK1727801T3 (da)	2009-05-11	Til behandling af smerter anvendelige piperaziner
DE60315490D1 (de)	2007-09-20	Therapeutische behandlung
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
EP1478356A4 (en)	2005-03-16	THERAPEUTIC COMPOUNDS
NO20052814D0 (no)	2005-06-10	Cytomodulerende peptider for behandling av interstitielle cystitt
DK2845594T3 (da)	2022-03-07	Anvendelse af dihydroimidazoloner til behandlingen af hunde.